China-focused infant formula firm Synutra International has cut its full-year sales and profits guidance following a weaker-than-expected first quarter. For the three months to the end of June, Synutra saw net sales rise by 22.5% to ...
The European Patent Office has granted patent No.1,793,809 to SCOLR Pharma's oral modified release ibuprofen formulation. The oral modified release ibuprofen formulation is based on the company's CDT controlled delivery technology ...